Valuation: DexCom, Inc.

Market Cap 3.48TCr 2.98TCr 2.79TCr 2.56TCr 4.8TCr 3,33400Cr 4.86TCr 33TCr 13TCr 1,67500Cr 13TCr 13TCr 5,54000Cr P/E 2026 *
37x
P/E 2027 * 31.1x
Enterprise Value 3.41TCr 2.92TCr 2.73TCr 2.5TCr 4.69TCr 3,26100Cr 4.76TCr 32TCr 13TCr 1,63800Cr 13TCr 13TCr 5,41900Cr EV / Sales 2026 *
6.52x
EV / Sales 2027 * 5.83x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+0.52%
1 week-1.52%
Current month+8.94%
1 month+16.07%
3 months+32.65%
6 months+26.75%
Current year+35.98%
1 week 76.8
Extreme 76.8
78.6
1 month 62
Extreme 62
79.2
Current year 48.8
Extreme 48.8
79.2
1 year 47
Extreme 47
79.2
3 years 47
Extreme 47
131.78
5 years 47
Extreme 47
145.65
10 years 47
Extreme 47
145.65
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
+0.52%-1.52% - - 3.4TCr
+2.19%+4.83%-11.93%+12.47% 20TCr
+1.14%+3.06%+0.14%+14.51% 12TCr
+1.06%+2.59%+4.73%+76.30% 6.01TCr
-1.37%-6.27%+28.79%+60.98% 5.32TCr
+2.33%+5.51%-3.61%-29.85% 5.11TCr
+2.35%+0.94%+13.06%-12.93% 3.4TCr
+5.16%-3.71% - - 2.86TCr
-0.20%+2.00%+43.31%-8.95% 2.49TCr
+0.93%+0.79%-4.66%+6.28% 2.3TCr
Average +1.41%-0.37%+8.73%+14.85% 6.56TCr
Weighted average by Cap. +1.50%+0.83%+1.26%+17.72%

Financials

2026 *2027 *
Net sales 523Cr 448Cr 419.19Cr 383.72Cr 720.13Cr 50TCr 729.64Cr 4.95TCr 1.93TCr 25TCr 1.96TCr 1.92TCr 83TCr 579.98Cr 496.81Cr 464.85Cr 425.52Cr 798.58Cr 55TCr 809.13Cr 5.49TCr 2.14TCr 28TCr 2.18TCr 2.13TCr 92TCr
Net income 97Cr 83Cr 78Cr 71Cr 134.16Cr 9.32TCr 135.93Cr 922.66Cr 359.81Cr 4.68TCr 365.86Cr 357.9Cr 15TCr 114.89Cr 98Cr 92Cr 84Cr 158.2Cr 11TCr 160.29Cr 1.09TCr 424.28Cr 5.52TCr 431.42Cr 422.03Cr 18TCr
Net Debt -76Cr -65Cr -61Cr -56Cr -104.8Cr -7.28TCr -106.19Cr -720.76Cr -281.07Cr -3.66TCr -285.8Cr -279.58Cr -12TCr -106.15Cr -91Cr -85Cr -78Cr -146.16Cr -10TCr -148.09Cr -1.01TCr -391.98Cr -5.1TCr -398.57Cr -389.9Cr -17TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
21/26/21 €78.00 +0.52% 0
20/26/20 €77.60 +0.52% 0
19/26/19 €77.20 -1.78% 0
18/26/18 €78.60 +2.34% 202
17/26/17 €76.80 -2.29% 34
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
92.34USD
Average target price
94.12USD
Spread / Average Target
+1.93%

Quarterly revenue - Rate of surprise